▎ 摘　　要

NOVELTY - Spinal cord fusion agent comprises polyethylene glycol, bone marrow mesenchymal stem cells, Schwann cells, glial cell-derived neurotrophic factor, nano graphene and nano cellulose. USE - The spinal cord fusion agent is useful in preparing medicament for treating central nervous system injury, and treating spinal cord injury, where the pathological manifestations of the spinal cord injury are gray matter separation of the spinal cord, white matter separation of the spinal cord, incomplete spinal cord and/or motor and sensory function defects below the injury level (all claimed). ADVANTAGE - The spinal cord fusion agent is statistically significant. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is also included for preparing the spinal cord fusion agent comprising, mixing polyethylene glycol, bone marrow mesenchymal stem cells, Schwann cells, glial cells derived neurotrophic factor, nano graphene and nano cellulose.